Multifunctional magnetic nanoparticles and derivative nanocomposites have aroused great
concern for multimode imaging and cancer synergistic therapies in recent years. Among the …

Immunotherapy is one of the most promising clinical modalities for the treatment of
malignant tumors and has shown excellent therapeutic outcomes in clinical settings …

Glioblastoma, the most common and aggressive primary brain tumor type, is considered an
immunologically “cold” tumor with sparse infiltration by adaptive immune cells …

Developing dynamic and highly sensitive methods for imaging M2‐type tumor‐associated
macrophages (TAMs) is vital for monitoring the tumor progression and assessing the …

Because of the blood–brain barrier and the high infiltration of glioma cells, the diagnostic
accuracy and treatment efficiency of gliomas are still facing challenges. There is an urgent …

Cancer is the top cause of death globally. Developing smart nanomedicines that are
capable of diagnosis and therapy (theranostics) in one–nanoparticle systems are highly …

The complex interaction between glioblastoma and its microenvironment has been
recognized for decades. Among various immune profiles, the major population is tumor …

The tumor immunosuppressive microenvironment (IME) significantly affects tumor
occurrence, progression, and prognosis, but the underlying molecular mechanisms remain …

In recent years, the development of advanced magnetic resonance imaging (MRI)
technology and machine learning (ML) have created new tools for evaluating treatment …

Nanomedicine research recently started exploring the combination of therapy and
diagnostics, so-called theranostics, as an approach to offer a more flexible, personal, and …